Fundraising FoxDAYLI Partners
Venture capitalSeoul · Seed–Late Stage · 13 people tracked
Find your way into DAYLI Partners
Sign up to see every warm intro you have to DAYLI Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DAYLI Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DAYLI Partners positions itself as a specialized investment group focused on the bio and healthcare industries as well as finance and corporate governance. Leveraging differentiated expertise and strong execution capabilities, the firm seeks to lead industry evolution and innovation through its investments, with the goal of creating sustainable performance and returns.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from curatedWhat they invest in
from 21 of 119 portfolio companiesBiotech ×12Healthtech ×11Medical Devices ×11AI & Machine Learning ×7Digital Health ×4Hardware ×3Advanced Manufacturing ×2Deep Tech ×2
HQs:South Korea×11United States×2Indonesia×1
Investments · 119 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 12017 · 12016 · 15 dated
Trinity Biotech develops and manufactures diagnostic products for the medical diagnostics market, selling directly in the United States and through international distributors and strategic partners in over 100 countries.
BiotechHealthtechMedical Devices
42Maru develops AI-powered question-answering and search technology that helps enterprises and application providers extract insights from large unstructured datasets.
AI & Machine LearningEnterprise SoftwareIoTRoboticsSaaSSeoul, KR
Co-investorsTechstarsDSC Investment
Korean startup making biopolymer-based artificial organs for medical device testing and surgical training simulators.
Steve Park(Founder)in
Co-investorsAscendo VenturesKB InvestmentKorea Investment Partners
Alodokter runs an Indonesian health platform that combines medical reference articles with direct chat access to licensed doctors.
Healthtech
Suci Arumsari(Founder)inNathanael Faibis(Founder)in
Co-investors500 GlobalGolden Gate VenturesWessel ManagementMDI VenturesSamsung Ventures
Arum Therapeutics is a biotechnology company developing therapeutics, with a research-focused pipeline.
Biotech
Mark Taegon Baik(Founder)inTaegon Baik(Management)Ha-Young Lee(Management)
Co-investorsAju IB InvestmentSBI Investment Korea Co. Ltd.
BreezeBio develops a programmable platform called NanoGalaxy for targeted delivery of genetic medicines, aiming to move genetic payloads to specific cells and tissues.
BiotechDeep TechLongevity
Co-investorsACVC PartnersDCVC (Data Collective)Kiwoom InvestmentSequoia CapitalDSC InvestmentKorea Investment Partners+3 more
CARUS Bio develops gene delivery systems and cell-derived biologics for therapeutic applications.
BiotechDeep TechHealthtechMedical DevicesSeoul, KR
신규 배
Circumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders.
BiotechDigital HealthHealthtechMedical DevicesPortland, US
Devin Wiley(Chief Medical Officer and Head of R\u0026D)inAndrew Lim(CEO)
Co-investorsY CombinatorStanford UniversityWestern Technology Investment
CMES Robotics builds AI-powered robotics systems that combine 3D vision and a proprietary AI core to inspect products, recognize objects, plan robot paths, and perform automated handling and manufacturing tasks.
Advanced ManufacturingAI & Machine LearningRobotics
Co-investorsAtinum Investment Co. Ltd.Kiwoom Investment
DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.
Biotech
Seulki Lee(Executive Officer, Director)inSunghoon Hong(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)
BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)
Co-investorsKiwoom InvestmentLB InvestmentMagna InvestmentOctave Ventures Llc
Enclony builds high-speed vision inspection systems for pharmaceutical manufacturing, used to inspect tablets, capsules, and tablet-capsule hybrids and to verify laser marking.
Advanced ManufacturingAI & Machine LearningHardwareHealthtechMedical Devices
Co-investorsAju IB Investment
G2GBIO (Good to the Globe Biotech) is a pharmaceutical company developing improved new drug injectable formulations, with platform technology applicable to treatments for various diseases and mass-production techniques.
BiotechMedical Devices
Co-investorsAtinum Investment Co. Ltd.Magna InvestmentKorea Investment Partners
BiotechNew York, US
Byungkyu Kang(Executive Officer, Director, Promoter)in
Co-investorsSpark Labs Korea Accelerator Fund 4SBVASparkLabs Global VenturesSparkLabs Korea
Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Jonathan Rothberg(Founder)in
Co-investorsDolby Family VenturesGV (Google Ventures)
Idience is a biopharmaceutical company focused on developing and commercializing new medicines.
BiotechDigital HealthHealthtech
Won Sik Lee(Chief Executive Officer)inKyoung Soo Ha(Chief Medical Officer)Eun Kyung Kang(Chief Regulatory and Quality Officer)
Co-investorsKiwoom Investment
South Korean biotech developing small-molecule ion channel drugs, led by Nav1.7 inhibitors for pain and Kv7 modulators for CNS disorders.
Co-investorsAju IB InvestmentKiwoom Investment
South Korean biotech in Daejeon developing OHPAS linker and payload modification technologies for antibody drug conjugates.
Daejeon, KR
Co-investorsAF WPartnersAtinum Investment Co. Ltd.
Jeisys is a company focused on aesthetic and medical treatment products, presenting itself as a global provider open to partnerships and product inquiries.
HealthtechMedical DevicesSeoul, KR
Dong Hwan Kang(Chairman of Jeisys Medical)inRami Lee(CEO of Jeisys Medical)in
Co-investorsAtinum Investment Co. Ltd.We Ventures
Medipixel develops AI-based clinical solutions in the medical technology field, working with hospitals and healthcare partners.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsAscendo VenturesCompany K PartnersMirae Asset Venture InvestmentPremier PartnersAI Angel ClubAscendo Ventures
NeuroXT develops MRI-based AI software that predicts amyloid and tau burden to guide Alzheimer's disease treatment decisions.
Co-investorsKakao VenturesAju IB InvestmentSmilegate Investment
NRISE operates consumer mobile services including Wippy, a social dating/matching app connecting men and women in their 20s-30s in Korea and Japan, and Quat, a home-training fitness subscription app.
ConsumerSocialWellness & Fitness
Kim Dae-geun(CTO)
Co-investorsColopl NextLB Investment
Healthcare company that recently went public.
Co-investorsAF WPartnersAscendo VenturesNH Investment & SecuritiesOasisPAG Japan
SKINGRAB is a South Korean manufacturer of energy-based aesthetic medical devices, including its FINIFF system, aimed at skincare professionals and patients.
HardwareHealthtechMedical Devices
SNVIA is a South Korean Pusan National University spin-off developing embeddable microneedle patches and therapeutic polymers.
Co-investorsColopl Next
Tomocube develops holotomography (HT), a label-free, non-invasive 3D microscopic imaging technology that combines with AI to visualize and quantify live cells, organoids, and tissue samples.
AI & Machine LearningBiotechHardware
VaxcellBio develops anti-cancer immunotherapies, including NK cell therapies, CAR cell therapies, targeted anti-cancer agents, and antibody treatments for cancers such as liver, small-cell lung, pancreatic, solid, and blood cancers.
BiotechHealthtechMedical Devices
Co-investorsAju IB InvestmentLB Investment
Y-Biologics (와이바이오로직스) develops antibody-based drugs using its antibody discovery, fully human antibody library, and antibody engineering technologies, working through its own pipeline and partner collaborations.
AI & Machine LearningBiotechHealthtechMedical DevicesDaejeon, KR
Co-investorsAju IB InvestmentIMM Investment JapanKiwoom InvestmentMagna InvestmentPearl Abyss Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1ST Biotherapeutics3D MedivisionAbClonAM ScienceAngel RoboticsAnterogenAston ScienceATsenseAUTOTAC BioBeamworksBiOrchestraBreeze BioCareNationCasCure TherapeuticsCdmoGenCellemedyCellidCelloramCharmacistCuraumCuriox BiosystemsCytoDxDAAN BiotherapeuticsDeepCardioDoctor DiaryDoctor NowDreamtechElgen TherapeuticselisiGenEnsol BiosciencesEutilexExosome PlusFNCT BiotechG2EGaluxGencellmedGenomictreeGI CellGI InnovationHuinnoHuons MeditechHysensBioIBEX Medical SystemsIllimis TherapeuticsJD BioscienceKanaph TherapeuticsKCell BiosciencesKey Prime ResearchLaSemillaLigachem BioscienceLive Cell InstrumentsLynk SolutecMalgeunaeilMaster MeditechMedifabMediOgenMeditrixMicrodigitalMthera PharmaMXT BiotechNextGen BioscienceNoulNovelty nobilityNuvi LabOn Us Link ItOnnuri StoreOptichoOrum TherapeuticsPantilogosPhantomicsPharmCADDPhASTPrecision BioPrimoris TherapeuticsProtium ScienceRanelaghRegen InnopharmRevosketchRibo TechSCM LifescienceSeaWithSL TherapeuticsSNBioscienceSpace FSugen TechT&R BiofabTENESTherapexTxinno BioscienceUbix TherapeuticsVIGENCELLWSG
Exits · 4
3 IPOs · 1 acquisitions · showing 1Trinity BiotechNASDAQ: TRIB
Portfolio news
latest coverage across their companies
Frequently asked questions
- How many investments has DAYLI Partners made?
- DAYLI Partners has 119 tracked investments, 4 of which have exited, including 3 dated in the last 24 months.
- What stage does DAYLI Partners invest at?
- DAYLI Partners invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does DAYLI Partners focus on?
- DAYLI Partners focuses on Biotech, Digital Health, Fintech, Healthtech, Medical Devices.
- Where is DAYLI Partners located?
- DAYLI Partners is headquartered in Seoul, KR.
- Who does DAYLI Partners co-invest with?
- DAYLI Partners most often shares deals with Aju IB Investment, Kiwoom Investment, Magna Investment, among 21 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.